Diagnostics Science Liaison, Oncology

Diagnostic Science Liaison, OncologyAstraZeneca is a global, science-led, patient-focused biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines for some of the world’s most serious diseases. But we’re more than one of the world’s leading pharmaceutical companies.ROLE SUMMARYThe Diagnostic Science Liaison (DSL) is a field-based diagnostics expert who advances precision oncology by enabling timely, accurate biomarker testing and optimal patient identification across the care pathway. Reporting to the Diagnostics Manager, the DSL is the primary scientific point of contact for molecular diagnostics within assigned institutions and regions, building partnerships with healthcare professionals (HCPs), pathology and laboratory networks, and relevant stakeholders to optimise testing access, quality, and utilisation.With deep scientific knowledge of diagnostic tests and practical understanding of operational issues across the testing pathway (pre‑analytical, analytical, post‑analytical), the Diagnostic Science Liaison engages in balanced and scientific exchange, identifies barriers and opportunities in the local diagnostic ecosystem, and translates insights to inform Medical and Diagnostic strategies. The DSL ensures the availability and correct use of in‑market companion and complementary diagnostics, fostering sustainable, high‑quality testing solutions throughout the patient journey. The role supports compliant education, evidence generation, and pathway optimisation to accelerate appropriate testing adoption and improve patient outcomes.What you’ll doBuild, enhance, and maintain advocacy with Key External Experts (KEEs) and stakeholdersIdentify, prioritise, and expand KEEs across oncology, pathology, molecular genetics, pulmonology, laboratory leadership and non‑traditional stakeholders (e.g., payers, policy makers, hospital administrators) based on scientific influence and potential to drive testing practice changeMap patient care and sample journeys within priority accounts/institutions, characterise multidisciplinary team maturity, and identify decision makers influencing testing protocols.Conduct objective and balanced scientific exchange discussions on biomarker biology, testing modalities, clinical pathways, and outcomes evidence to increase awareness of the clinical impact of testing.Identify and develop speakers, and recommend advisory board/round‑table participants to provide expertise on testing standards and protocols.Generate actionable insights on testing behaviours, barriers and opportunities and share with cross‑functional teams to inform planning and address unmet needs.Build and implement diagnostic programmes to address unmet medical and diagnostics needsFacilitate continuous medical education and execute compliant diagnostic programmes and materials that demonstrate clinical utility and outcomes to accelerate HCP adoption of appropriate testing.Define and refine the end‑to‑end patient and sample journey in each strategic account; identify main patient leakage points and implement solutions to remove access barriers for HCPs and patients.Expand availability of testing beyond companion diagnostics by identifying, validating, and onboarding appropriate local/central lab solutions and platforms, support lab readiness, capacity, and business continuity in collaboration with internal stakeholders.Support monitoring and improvement of testing quality and accuracy.Contribute to Medical and Diagnostic StrategyProvide structured, timely feedback on local testing trends, unmet needs, and competitor diagnostics, and translate insights into recommendations for account plans, medical priorities and evidence needs.Execute diagnostic activities within priority accounts to optimise impact on patient identification and treatment initiation.Deliver internal trainings on biomarkers, testing pathways, local ecosystem and quality considerations, as needed.Facilitate local evidence generationLead or support local/regional evidence generation on testing quality, clinical utility, turnaround time, and biomarker prevalence and partner with Evidence Generation/Medical teams to address evidence gaps that influence adoption and guideline inclusion.Upon request, support feasibility, site selection, and operations for clinical studies focused on diagnostics and testing pathways.Corporate responsibility and GovernanceEnsure compliance with AZ Code of Ethics, corporate governance, audit requirements, guidelines, industry codes, policies and procedures, and disclose potential breach.Ensure that company confidentiality is maintained (i.e. intellectual property, product, strategic and salary information).Ensure patient confidentiality and safety are safeguarded.Ensure that all conducted activities are done in accordance with local legislation and corporate standards.Report health/ environment/ wellbeing related accidents, adverse events, and conflict of interest as p